Biomed Central Ltd

SHERPA: Unknown

People

  1. Postow
    Postow
  2. D'Angelo
    D'Angelo
  3. Offit
    Offit
  4. Budhu
    Budhu
  5. Motzer
    Motzer
  6. Shoushtari
    Shoushtari
  7. Voss
    Voss
  8. O'Reilly
    O'Reilly
  9. Robson
    Robson
  10. Autio
    Autio

Groups

  1. Department of Medicine (461)
  2. Solid Tumor Oncology Division (461)
  3. GSK Faculty (161)
  4. Melanoma and Immunotherapeutics Service (148)
  5. Hematologic Malignancies, Division of (99)
  6. Hematology-Oncology Fellows (85)
  7. Genitourinary Oncology Service (81)
  8. Melanoma Disease Management Team (78)
  9. Sloan Kettering Institute Postdocs (76)
  10. Weinberg Fellows (70)
Search Within
  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (220)
  2. Meeting Abstract (210)
  3. Guidelines (12)
  4. Review (9)
  5. Editorial (7)
  6. Correspondence (1)
  7. Miscellaneous (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (461)
  2. Solid Tumor Oncology Division (461)
  3. GSK Faculty (161)
  4. Melanoma and Immunotherapeutics Service (148)
  5. Hematologic Malignancies, Division of (99)
  6. Hematology-Oncology Fellows (85)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Michael Postow (43)
  4. Matthew Hellmann (30)
  5. Sandra D'Angelo (26)
  6. Kenneth Offit (23)

More People

Years
  1. 2025 (12)
  2. 2024 (23)
  3. 2023 (20)
  4. 2022 (74)
  5. 2021 (58)
  6. 2020 (60)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (322)
  2. Breast Cancer Research (32)
  3. BMC Cancer (25)
  4. Journal of Translational Medicine (23)
  5. Genome Medicine (9)
  6. Journal of Hematology & Oncology (8)

More Publications

Results (461)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients
    Journal Article

    Machiels, J. P.; Gomez-Roca, C.; Michot, J. M.; Zamarin, D.; Mitchell, T.; Catala, G.; Eberst, L.; Jacob, W.; Jegg, A. M.; Cannarile, M. A.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
    Journal Article

    Garrido-Castro, A. C.; Saura, C.; Barroso-Sousa, R.; Guo, H.; Ciruelos, E.; Bermejo, B.; Gavilá, J.; Serra, V.; Prat, A.; Paré, L.; more...
    Breast Cancer Research (2020)

    Fulltext@MSK | Save
  • Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer
    Journal Article

    Friedman, C. F.; Snyder Charen, A.; Zhou, Q.; Carducci, M. A.; Buckley De Meritens, A.; Corr, B. R.; Fu, S.; Hollmann, T. J.; Iasonos, A.; Konner, J. A.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Perspectives in melanoma: Meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)
    Editorial

    Ascierto, P. A.; Puzanov, I.; Agarwala, S. S.; Blank, C.; Carvajal, R. D.; Demaria, S.; Dummer, R.; Ernstoff, M.; Ferrone, S.; Fox, B. A.; more...
    Journal of Translational Medicine (2020)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
    Journal Article

    Reuss, J. E.; Anagnostou, V.; Cottrell, T. R.; Smith, K. N.; Verde, F.; Zahurak, M.; Lanis, M.; Murray, J. C.; Chan, H. Y.; McCarthy, C.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns
    Journal Article

    Mateo, L.; Duran-Frigola, M.; Gris-Oliver, A.; Palafox, M.; Scaltriti, M.; Razavi, P.; Chandarlapaty, S.; Arribas, J.; Bellet, M.; Serra, V.; more...
    Genome Medicine (2020)

    Fulltext@MSK | Save
  • Circulating bilirubin levels and risk of colorectal cancer: Serological and Mendelian randomization analyses
    Journal Article

    Seyed Khoei, N.; Jenab, M.; Murphy, N.; Banbury, B. L.; Carreras-Torres, R.; Viallon, V.; Kühn, T.; Bueno-de-Mesquita, B.; Aleksandrova, K.; Cross, A. J.; more...
    BMC Medicine (2020)

    Fulltext@MSK | Save
  • Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance status
    Journal Article

    Alessi, J. V.; Ricciuti, B.; Jiménez-Aguilar, E.; Hong, F.; Wei, Z.; Nishino, M.; Plodkowski, A. J.; Sawan, P.; Luo, J.; Rizvi, H.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: A study within a trial
    Journal Article

    Pace, L. E.; Lee, Y. S.; Tung, N.; Hamilton, J. G.; Gabriel, C.; Raja, S. C.; Jenkins, C.; Braswell, A.; Domchek, S. M.; Symecko, H.; more...
    BMC Medical Research Methodology (2020)

    Fulltext@MSK | Save
  • Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial
    Journal Article

    Motzer, R. J.; Escudier, B.; McDermott, D. F.; Frontera, O. A.; Melichar, B.; Powles, T.; Donskov, F.; Plimack, E. R.; Barthélémy, P.; Hammers, H. J.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save